EFFECT OF EMPAGLIFLOZIN ON MORTALITY AND CAUSES OF DEATH IN PATIENTS WITH TYPE 2 DIABETES AT HIGH CARDIOVASCULAR RISK
Fitchett, D., Inzucchi, S., Lachin, J.M., Wanner, C., Mattheus, M., Johansen, O., Woerle, H., Broedl, U.C., Zinman, B.Volume:
32
Language:
english
Journal:
Canadian Journal of Cardiology
DOI:
10.1016/j.cjca.2016.07.182
Date:
October, 2016
File:
PDF, 332 KB
english, 2016